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Summary A new cell line (CAL51) was isolated from a malignant pleural effusion of a woman with
metastatic breast cancer. These cells grow in continuous culture and exhibit the morphological, ultrastructural
and immunohistochemical features of epithelial cells of mammary origin. They are tumorigenic in nude mice
and clone in soft agar. Oestrogen receptors are not detected. CAL51 consists of a homogeneous population of
cells with normal chromosomes even after the use of high resolution banding. Cytogenetic analysis of the cells
from the tumour induced by CAL51 in the nude mouse confirmed the normality and the stability of the
karyotype. All breast cancer cell lines established to date present abnormal karyotypes; CAL51 cell line may
be more informative than cell lines with aberrant karyotypes for investigating essential genetic differences
between normal and malignant mammary gland cells.
Breast adenocarcinomas are among the most frequent
cancers in women. These generally slow-growing tumours
present a wide sprectrum of clinical courses that sometimes
defy all attempts at prognosis and treatment.
In vitro models are required for the study of these cancers,
and several cell lines have already been established and char-
acterised (Lafargues & Ozzello, 1958; Soule et al., 1973;
Cailleau et al., 1974; Engel et al., 1978; Whitehead et al.,
1983; Yamane et al., 1984; Chu et al., 1985; Vandewalle et
al., 1987). Nevertheless, owing to the heterogenity and the
diversity of mammary cancers, a great number of cell models
is necessary to understand the reasons for this diversity and
the effect of anticancer drugs on tumour cells.
Cytogenetic studies of mammary adenocarcinoma cell lines
are essential for comprehension of the pathogenesis of these
cancers (Trent, 1985; Gebhart et al., 1986). The implication
of chromosomal alterations in these pathologies has opened a
new and promising route towards better knowledge of these
cancers (Cervenka & Koulischer, 1973). Chromosomal altera-
tions are generally numerous, and markers often demonstrate
hyperploidy in these cancers (Sandberg, 1980).
Demonstration of the minimum genetic alterations indis-
pensable for cell transformation is difficult, and might be
easier on cells with a karyotype closer to normal. Sandberg
and Wolman mentioned the existence of such cells, but most
of their results concerned karyotype studies without chromo-
some banding (Sandberg, 1980; Wolman, 1983).
CAL51, corresponding to a cell population with a 'normal'
karyotype, is a new mammary adenocarcinoma cell line
derived from the malignant pleural effusion of a patient
treated at the Antoine-Lacassagne Cancer Center (Nice,
France).
Materials and methods
Patient and cell culture
This 44-year-old woman was seen in January 1984 for pro-
gressive breast cancer. After chemotherapy, she underwent
bilateral mastectomy with resection ofpositive axillary nodes;
histology diagnosed invasive adenocarcinoma with extensive
intraductal involvement. Oestrogen and progesterone recep-
tors were both negative. After radiotherapy and chemo-
therapy, she presented in August 1985 with cutaneous,
osseous and hepatic metastases and bilateral pleural effusion.
On 4 October 1985, thoracocentesis produced numerous
clumps of cancerous cells that were cultivated.
The cells were maintained in Dulbecco's modified mini-
mum essential medium with Earle's salts (DMEM) (Boeh-
ringer, France SA) supplemented with 0.6 tg ml-' bovine
insulin, 5 x 10 3fig ml ' transferrin, 2 mmol L-glutamine,
10% fetal calf serum, 400 U ml-' penicillin, and 200figml-I
streptomycin. Cells were stored in an incubator at 37°C in a
5% CO2 atmosphere.
Doubling time
At passages 15 and 50, 12 x 104 cells were plated in Falcon
plastic flasks (25 cm2) containing complete culture medium.
Cells were harvested with a solution of 0.05% trypsin in
phosphate-buffered saline (PBS) and were counted every day
for 11 days starting 24 h after plating.
Electron microscopy
The cell layer was scraped with a rubber policeman to obtain
groups of cells. After centrifugation, the residue was fixed
twice with 1.25% cold glutaraldehyde and 2% osmic acid at
room temperature for 30 min. The cells were then dehydrated
by rinses of increasing concentrations of alcohol and pro-
pyline oxide. The residue was embedded in Epon. Sections
were prepared with an LKB Nova ultramicrotome; grids
were stained by the LKB Ultrastainer and the sections were
examined with a Philips CM 12 (20 keV) electron micro-
scope.
Chromosomal analysis
Cytogenetic examination of CAL51 cells was performed at
around passage 13. Cells in the exponential phase of growth
were treated with colchicine (Seromed, Biopro) for 1/2 h at a
final concentration of 1 fig ml-'. Cells were then trypsinised,
washed and treated for 45 min with a hypotonic solution
(0.075 M KCI, EGTA 0.2 g [-', hyaluronidase 25 IU for
20 ml, Hepes buffer 4.8 g 1' in distilled water). Cells were
then fixed in acetic acid:methanol (1:3) and dropped onto
grease-free, cooled slides for chromosome counting and
examination. R bands were obtained by heat denaturation of
the chromosomes according to the method of Dutrillaux and
Lejeune (1971). Xenografted CAL51 cells were plated and
studied in vitro in the same manner.
Further studies at passage 17 for CAL51 and at passage 9
for xenografted CAL51 cells using thymidine synchronisation
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and BrdU incorporation (Viegas-Pequignot & Dutrillaux,
1978) were developed with some differences since an incuba-
tion of 18-20 h with a final concentration of 10tig of BrdU
per ml was required to study replication banding pattern and
high resolution banding. ISCN T, C and Q-banding (ISCN,
1985) were applied on some preparations.
Immunochemical studies
Peroxidase labelling was performed to reveal the oestrogen
receptors and the epithelial nature of the cells. CAL51 cells
were cultured on glass slides for both experiments, then fixed.
After indirect immunoassay (peroxidase antiperoxidase), cells
were stained with Harris' haematoxylin.
Oestrogen receptors Cells were fixed with 3.7% formal-
dehyde in PBS, then with pure methanol and acetone. The
specific monoclonal antibody used was H222SP gamma from
the ER-ICA kit (Abbott).
Epithelial nature of the cells Cells were fixed with acetone.
An antikeratin monoclonal antibody (KLI-Immunotech)
diluted to 1:50 and an anti-epithelial membrane antigen
(DAKO, EMA) diluted to 1:25 were used. The same
experiments were performed on paraffin sections of the
primary tumour of this patient and on a section of a tumour
induced in the nude mouse by CAL51.
Clonogenic growth in soft agar
Cells were cultured as described by Salmon et al. (1978). In
brief, cells were suspended on 0.3% agar in enriched Con-
naught Medical Research Laboratories Medium 1066 (Grand
Island Biological Co., Grand Island, NY, USA) with 15%
horse serum (Flow Laboratories, Puteaux, France) in 35 mm
Petri dishes containing an underlayer of 0.5% agarose in
culture medium. Cells were then incubated at 37°C in a
humidified atmosphere of 5% CO2 and 95% air. Plates were
examined with an inverted phase microscope 21 days after
plating. Positive controls were obtained in the same condi-
tions using melanoma cell line CALl, which clones in soft
agar (Courdi et al., 1983).
Tumorigenicity
Six-week-old athymic nude mice with the Swiss genetic back-
ground (IFFA Credo Laboratories, France) were used. Some
2 x 106 cells in 0.2 ml Ringer lactate solution were inoculated
s.c. into both flanks of three mice.
Results
Morphology by light microscopy
After culturing, epithelial cells appeared rapidly. Figure 1
shows the CAL51 cells as they appeared under light micro-
scopy. These heterogeneous cells (small, polyhedric cells or
Figure 1 Photomicrograph of cell line CAL51 ( x 70).
larger, more rounded cells) showed anchorage-independent
growth. They presented visible nuclear abnormalities. The
first passage was performed one month after initiation of
culture. Cells were maintained in culture until passage 40,
then conserved in liquid nitrogen.
Doubling time
CAL51 cells grow exponentially up until day 8, when they
reach a plateau phase. The population doubling time was
measured during the period of exponential growth: 45 h at
passages 15 and 50.
Electron microscopy
CAL51 cells all have a large nucleus with irregular contours
and a large nucleolus. The cytoplasm contains abundant
ribosomes (free or organised in ergastoplasmic cisternae),
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Figure 2 Electron micrograph of cell line CAL51: a, zonula
adhaerens (ZO) ( x 17,000); b, microfilaments (MF) ( x 17,000).10 J. GIOANNI et al.
mitochondria, rather numerous Golgi bodies and some lyso-
somes. The cells are often contiguous and have zonula-
adhaerens junctions (Figure 2a). Certain cells contain numer-
ous bundles of microfilaments organised around electron-free
cavities (Figure 2b). Their apical poles are covered with
microvilli suggesting glandular luminae.
Chromosomal analysis
T, R, Q and C-banding Cytogenetic analysis of cell line
CAL51 revealed normal diploidy; the average number of
chromosomes per cell analysed was 46 (Figure 3). The karyo-
type was normal: no structural abnormality was seen by
R-banding. Cytogenetic analysis of xenografted CAL51 cells
plates in vitro gave the same results. Some metaphases were
incomplete, and others carried one or two abnormal chro-
mosomes. Since these anomalies were not recurrent, it is very
likely that they were generated from cells with normal karyo-
type at late passages. The tetraploid metaphases or pro-
metaphases had no additional anomalies. R and T-banding
(Dutrillaux & Couturier, 1981), allowing an identification of
the polymorphism which may exist on the short arms of the
acrocentrics, clearly showed that the parental chromosomes
were present for pairs 13, 14, 15, 21 and 22 (Figure 4).
Q-bands confirmed this interpretation and exhibited a poly-
morphism for chromosome 3. Finally, chromosomes 9 could
be differentiated by their heterochromatin.
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Figure 3 Chromosome number distribution in a sample of 100
CAL51 cells.
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Figure 4 Conservation of heteromorphism of heterochromatic regions. First row, Q-banding; second row, Giemsa staining of the
same chromosomes; third row, R-banding of acrocentric chromosomes; fourth row, Q-banding of chromosomes 3 and R-banding
after heat denaturation or Brd U incorporation (right) of chromosomes 9.
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High resolution banding Apart from the fact that a high
proportion of tetraploidy was found in CALS1 cells and in
xenografted cells as well, no recurrent abnormalities could be
observed in the 35 established karyotypes. After synchronisa-
tion and BrdU incorporation, a normal replication pattern
was observed (Figure 5). In some prometaphases, a high
number of bands per cell could be analysed, and yet, no
anomalies could be detected. The only abnormal parameter
was that a 18-20h treatment by BrdU was necessary to
obtain a replication banding pattern equivalent to a 7h
treatment in lymphocytes. This indicates a very low cell cycle,
specially for the late S and G2-phases.
Immunochemical studies
Oestrogen receptors (ER) The results are negative. This is
not surprising because the patient's primary tumour was ER
negative.
Epithelial nature of the cells Reactivities with antibodies
KLI and anti-EMA were strongly positive (Figure 6a). The
same was true for the section of the original tumour and the
section of the tumour induced by CAL51 in a nude mouse
(Figure 6b).
Cloning in soft agar
CAL51 cells had a cloning efficiency of 5.9%.
Figure 5 Karyotype of cell line CALS1 obtained from xenografted tumour cells
passages into nude mice). R-bands were obtained by a 20 h BrdU incorporation.
Tumorigenicity
Ten days after inoculation of CALS1 cells, four tumours
appeared at six injection sites. The xenografts were excised
after 1.5 months and put back in culture. The cells obtained
were identical to those of cell line CAL51. Histological
examination of the grafted tumours diagnosed differentiated
adenocarcinoma (Figure 7a). A histologic section of this
patient's tumour is shown in Figure 7b for comparison.
Discussion
Characterisation of CAL51 cells revealed that these epithelial
cells are unquestionably of mammary origin. They are
tumorigenic in nude mice and clone in soft agar. Because
their phenotype is stable in culture and their doubling time is
suitable for kinetics studies, they are a valuable model system
for the study of mammary adenocarcinoma. Their main orig-
inality is their normal karyotype. CAL51 consists of a
population of diploid cells with normal chromosomes after
metaphase and high resolution bandings. Since a proportion
of metaphases exhibited non-clonal anomalies, such as
chromosome gains or losses, or structural rearrangements, it
is likely that a certain chromosomal instability exists. In
some cultures, these cells undergo endoreduplication without
additional anomalies. At least for acrocentrics and chromo-
(after 13 in vitro passages followed by five12 J. GIOANNI et al.
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Figure 6 Immunoperoxidase staining of CAL51 with antikeratin Figure 7 a, Grafted tumour (differentiated adenocarcinoma)
antibodies: a, culture on glass slides (x 700); b, section of xenog- (x 175). b, Primary tumour of the patient (poorly differentiated
rafted tumour (x 175). carcinoma) (x 175).
somes 1 and 9 where it could be investigated no loss of
heterozygosity was detected, even for chromosome 13 for
which losses frequently occur (Gerbault-Seureau et al., 1987;
Lundberg et al., 1987). The phenotype of these cells and their
high tumorigenicity indicate that they are not normal con-
taminating cells, which could have been present in the pleural
effusion and which can be maintained in vitro. Cytogenetic
analysis of the cells from the tumour induced by CAL51 in
the nude mouse confirmed the 'normality' and the stability of
the karyotype. This fact is not exceptional, and has already
been observed by other authors. In his review of human
breast cytogenetics, based principally on unbanded cases,
Sandberg (1980) stated that diploid metaphases are occa-
sionally observed. Trent (1985) also cited the work by Wol-
man (1983), who found karyotypically normal diploid cells in
primary mammary adenocarcinomas but not in metastatic
effusions.
These authors all concluded that acquisition of an abnor-
mal karyotype is indicative of malignant progression rather
than initial events in tumorigenesis. As mentioned by Trent
(1985) and Smith et al. (1985), it could be questioned
whether diploid cells are really representative of the tumoral
population. In culture since October 1985, cell line CAL51
has conserved a diploid karyotype with normal chromo-
somes. They still produce tumours in nude mice, which is an
argument to consider that they represent the original cancer.
The genetic alterations responsible for the transformation
into cancerous cells should exist in the genome of CAL51
cells, but they are not visible on the chromosomes, even after
high resolution banding. Molecular studies might demon-
strate these alterations, which may be minimal, at difference
with most established cancer cell lines in which, the chromo-
somal damage is so extensive that the most characteristic
aberrations are difficult to single out. CAL51 is an ideal
model for investigating essential genetic alterations involved
in malignant transformation of mammary gland cells.
The authors wish to thank Nancy Rameau, Claude Menghelli and
Bernard Fontaine for their assistance in preparation of this manu-
script.
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